Valproic acid drug delivery systems and intraocular...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 31/19 (2006.01)

Patent

CA 2752206

Biocompatible, bioerodible, sustained release drug delivery system formulated as implants, microspheres and high viscosity hyaluronic acid solutions comprise valproic acid as therapeutic agent and a biodegradable polymer, the system being effective, when placed intraocular (such as into the subtenon space or into the vitreous) to treat a retinal disease or condition.

L'invention porte sur un système d'administration de médicament à administration entretenue, bioérodable, biocompatible, formulé sous la forme d'implants, de microsphères et de solutions d'acide hyaluronique à viscosité élevée, comprenant de l'acide valproïque en tant qu'agent thérapeutique et un polymère biodégradable, le système étant efficace lorsqu'il est placé de façon intraoculaire (tel que dans l'espace sous-épiscéral ou dans le corps vitré) pour traiter une maladie rétinienne ou un état rétinien.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Valproic acid drug delivery systems and intraocular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Valproic acid drug delivery systems and intraocular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Valproic acid drug delivery systems and intraocular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1602903

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.